ATE253076T1 - Antithrombosemittel - Google Patents

Antithrombosemittel

Info

Publication number
ATE253076T1
ATE253076T1 AT99305978T AT99305978T ATE253076T1 AT E253076 T1 ATE253076 T1 AT E253076T1 AT 99305978 T AT99305978 T AT 99305978T AT 99305978 T AT99305978 T AT 99305978T AT E253076 T1 ATE253076 T1 AT E253076T1
Authority
AT
Austria
Prior art keywords
dvt
occlusion
coagulation
grafts
arterio
Prior art date
Application number
AT99305978T
Other languages
English (en)
Inventor
Julian Blagg
Alan Daniel Brown
Elisabeth Colette Loui Gautier
Julian Duncan Smith
Andrew Brian Mcelroy
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9817819.7A external-priority patent/GB9817819D0/en
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE253076T1 publication Critical patent/ATE253076T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
AT99305978T 1998-08-14 1999-07-28 Antithrombosemittel ATE253076T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9817819.7A GB9817819D0 (en) 1998-08-14 1998-08-14 Antithrombotic agents
GB9900801 1999-01-14
US09/372,200 US6180627B1 (en) 1998-08-14 1999-08-11 Antithrombotic agents

Publications (1)

Publication Number Publication Date
ATE253076T1 true ATE253076T1 (de) 2003-11-15

Family

ID=27269438

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99305978T ATE253076T1 (de) 1998-08-14 1999-07-28 Antithrombosemittel

Country Status (10)

Country Link
US (1) US6180627B1 (de)
EP (1) EP0997474B1 (de)
JP (1) JP3258297B2 (de)
AT (1) ATE253076T1 (de)
BR (1) BR9903628A (de)
CA (1) CA2280279C (de)
DE (1) DE69912379T2 (de)
DK (1) DK0997474T3 (de)
ES (1) ES2209337T3 (de)
PT (1) PT997474E (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610692B1 (en) * 1998-10-30 2003-08-26 Merck & Co., Inc. Thrombin inhibitors
WO2000026210A1 (en) * 1998-10-30 2000-05-11 Merck & Co., Inc. Thrombin inhibitors
US6716838B1 (en) 1999-05-19 2004-04-06 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents
US6653316B1 (en) * 1999-05-19 2003-11-25 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
US6906068B1 (en) 1999-05-19 2005-06-14 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl 1,2,4 - triazinones useful as anticoagulants
US6867217B1 (en) * 1999-05-19 2005-03-15 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
US6458952B1 (en) * 1999-05-19 2002-10-01 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
US6664255B1 (en) 1999-05-19 2003-12-16 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
US7015230B1 (en) 1999-05-19 2006-03-21 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
US6750342B1 (en) 1999-05-19 2004-06-15 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
US6908919B2 (en) * 1999-05-19 2005-06-21 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
US6660885B2 (en) * 2000-03-13 2003-12-09 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
CA2403558A1 (en) 2000-03-23 2001-09-27 Merck & Co., Inc. Thrombin inhibitors
PT1268463E (pt) * 2000-04-05 2005-05-31 Pharmacia Corp 4-pironas substituidas com arilo e heteroarilo policiclicos uteis para a inibicao selectiva da cascata de coagulacao
US6693121B2 (en) 2000-04-05 2004-02-17 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
US6686484B2 (en) 2000-04-17 2004-02-03 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade
US7015223B1 (en) 2000-11-20 2006-03-21 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade
US7119094B1 (en) 2000-11-20 2006-10-10 Warner-Lambert Company Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade
WO2002042272A2 (en) 2000-11-20 2002-05-30 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
US20030236257A1 (en) * 2001-04-04 2003-12-25 South Michael S. Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the cogulation cascade
KR100965201B1 (ko) * 2001-06-12 2010-06-24 웰스테트 테라퓨틱스 코포레이션 대사 질환의 치료용 화합물
US20040082585A1 (en) * 2001-10-03 2004-04-29 Pharmacia Corporation Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
JP2005519866A (ja) 2001-10-03 2005-07-07 ファルマシア・コーポレーション 凝固カスケードの選択阻害に有用な６員複素環式化合物
US20040106626A1 (en) * 2001-10-03 2004-06-03 Pharmacia Corporation 6-Membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade
EP1432687A2 (de) 2001-10-03 2004-06-30 Pharmacia Corporation Substitutierte fünfgliedrige polyzyclischen vebindungen für die selektive hemmung der koagulationskaskade
CA2392486A1 (en) 2002-07-05 2002-12-08 Duchesnay Inc. Pharmaceutical dosage form bearing pregnancy-friendly indicia
US8673924B2 (en) * 2002-09-04 2014-03-18 Merck Sharp & Dohme Corp. Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
US8580782B2 (en) * 2002-09-04 2013-11-12 Merck Sharp & Dohme Corp. Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
RU2380369C9 (ru) 2002-09-04 2011-07-10 Шеринг Корпорейшн Новые пиразолопиримидины как ингибиторы циклин-зависимой киназы
AR060535A1 (es) * 2006-04-20 2008-06-25 Glaxo Group Ltd Pirido-piridazinonas y ftalazinonas como antagonistas duales de los receptores h1 y h3 de histamina
ATE459358T1 (de) * 2006-12-20 2010-03-15 Glaxo Group Ltd 4-benzyl-1(2h)-phthalazinone als h1-rezeptor- antagonisten
US20100216799A1 (en) * 2007-10-11 2010-08-26 Glaxo Group Limited Phthalazine and pyrido[3,4-d]pyridazine compounds as h1 receptor antagonists
RU2477144C2 (ru) * 2010-03-22 2013-03-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Российской академии медицинских наук Лекарственное средство с антиаритмическим и антифибрилляторным действием
RU2613155C1 (ru) * 2016-05-25 2017-03-15 Общество с ограниченной ответственностью "Саентифик Фьючер Менеджмент" (ООО "СФМ") Способ лечения больных с острыми тромбозами венозного русла нижних конечностей
JP7775080B2 (ja) 2019-07-01 2025-11-25 トニックス ファーマ リミテッド 抗ｃｄ１５４抗体およびその使用
US20240059781A1 (en) 2021-01-06 2024-02-22 Tonix Pharma Limited Methods of inducing immune tolerance with modified anti-cd154 antibodies
WO2025248134A1 (en) 2024-05-31 2025-12-04 Tonix Pharma Limited Treatment methods comprising administration of modified cd154 antibodies

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06329627A (ja) 1993-05-03 1994-11-29 Bristol Myers Squibb Co グアニジニル−またはアミジニル−置換ヘテロ環トロンビンインヒビター
GB9322976D0 (en) 1993-11-08 1994-01-05 Pfizer Ltd Therapeutic agents
AU691673B2 (en) * 1994-11-14 1998-05-21 Dow Agrosciences Llc Pyridazinones and their use as fungicides
GB9424842D0 (en) * 1994-12-09 1995-02-08 British Tech Group Pharmaceutical compositions
DE69526677T2 (de) 1994-12-13 2002-12-05 Corvas International, Inc. Aromatische heterocyclische derivate als enzyminhibitoren
AU703744B2 (en) 1995-06-27 1999-04-01 Merck & Co., Inc. Pyridinone-thrombin inhibitors
AU720616B2 (en) 1996-02-22 2000-06-08 Merck & Co., Inc. Pyridinone thrombin inhibitors
CA2252964A1 (en) * 1996-04-23 1997-10-30 Merck & Co., Inc. Pyrazinone thrombin inhibitors
JP2002511052A (ja) * 1996-08-29 2002-04-09 メルク エンド カンパニー インコーポレーテッド インテグリンアンタゴニスト
AU4172397A (en) 1996-09-06 1998-03-26 Biochem Pharma Inc. Lactam inhibitors of thrombin
CA2268381A1 (en) 1996-10-11 1998-04-23 Cor Therapeutics, Inc. Selective factor xa inhibitors
EP0934064B1 (de) * 1996-10-24 2003-03-12 Merck & Co., Inc. Thrombin inhibitoren
IL123986A (en) * 1997-04-24 2011-10-31 Organon Nv Medicinal compounds
JP2001514227A (ja) 1997-09-05 2001-09-11 メルク エンド カムパニー インコーポレーテッド ピラジノン系トロンビン阻害薬

Also Published As

Publication number Publication date
JP2000063380A (ja) 2000-02-29
EP0997474A1 (de) 2000-05-03
EP0997474B1 (de) 2003-10-29
DK0997474T3 (da) 2004-02-09
PT997474E (pt) 2004-01-30
DE69912379T2 (de) 2004-05-06
CA2280279A1 (en) 2000-02-14
DE69912379D1 (de) 2003-12-04
US6180627B1 (en) 2001-01-30
CA2280279C (en) 2004-02-17
BR9903628A (pt) 2000-09-26
JP3258297B2 (ja) 2002-02-18
ES2209337T3 (es) 2004-06-16

Similar Documents

Publication Publication Date Title
ATE253076T1 (de) Antithrombosemittel
US6463934B1 (en) Method for providing enhanced blood circulation
DE60143909D1 (de) Z und gefässokklusionsverschluss
AU2001264859A1 (en) Method for providing enhanced blood circulation
DK0964646T3 (da) Kirurgisk spærhage
FI952593A0 (fi) Hyytymistä estävä aine
DE69834724D1 (de) Behandlung von Darm- oder Blasenentzündungen
DE58906814D1 (de) Verwendung von ACE-Inhibitoren gegen Neointimabildung nach Gefässverletzung.
ATE498305T1 (de) Vermeidung und behandlung von krankheiten, die mit der blutgerinnung in zusammenhang stehen
RU98107980A (ru) Способ хирургического лечения ишемической болезни сердца
GB2333964B (en) Intravenous coagulation catheter for treatment of varicose veins
RU93015924A (ru) Способ лечения трофических язв нижних конечностей
SU1680092A1 (ru) Способ хирургического лечени хронической артериальной недостаточности нижних конечностей
Ikeda et al. Obstruction of the radial artery passing beneath the biceps brachii tendon—a case report
UA43082A (uk) Спосіб покращення артеріального кровообігу при атеросклеротичній оклюзії артерій стегново-підколінного сегмента
UA41150A (uk) Спосіб лікування критичної ішемії нижніх кінцівок
RU98109286A (ru) Способ хирургического лечения окклюзирующих заболеваний периферических артерий нижних конечностей
RU93045689A (ru) Способ лечения хронической артериальной недостаточности конечностей
RU97119966A (ru) Способ лечения жировой эмболии при переломах длинных трубчатых костей конечностей
RU98109687A (ru) Способ хирургического лечения облитерирующего эндартериита нижних конечностей
UA31749A (uk) Спосіб лікування множинних оклюзійно-стенотичних уражень артерій нижньої кінцівки
RU99105622A (ru) Способ хирургического лечения ишемической болезни сердца
UA55493C2 (uk) Спосіб зниження тромбогенності ендартеректомованої артерії
MD2029F1 (en) Freely combined autoplastic graft

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0997474

Country of ref document: EP

REN Ceased due to non-payment of the annual fee